Even as many people return to normal, some families are shaping their holiday 2022 plans around avoiding COVID-19
and fibromyalgia for 22 years, ever since she caught mono as a teenager and never fully recovered. A common cold can land her in bed for six weeks. COVID-19, her doctor warned her in 2020, could be catastrophic for her health.
“It’s always been very important for me to have an open house for anybody who didn’t have a place to go” over the holidays, Karen says. But these days, her doors remain closed to everyone except her husband’s parents, who live locally and lead a similarly locked-down lifestyle. He may go home for the winter holidays, he says, since he’ll have more time to quarantine and test beforehand. Max says he’d feel fine dropping those precautions if his parents no longer requested them, but for now, he’s happy to do what will make them comfortable. “I understand the principle that the more at-risk people set the rules,” he says.
“You grieve your plans and the reality you thought you were going to have and what you thought life was going to look like,” she says. “When you get to acceptance, then the question becomes, ‘Am I going to sit around and bemoan the existence of a life I wish I had, or am I going to pivot?’”
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
The negative impact of COVID-19 on working memory revealed using a rapid online quizAlthough coronavirus disease 2019 (COVID-19) affects the respiratory system, it can also have neurological consequences leading to cognitive deficits such as memory problems. The aim of our study was to assess the impact of COVID-19 on working memory function. We developed and implemented an online anonymous survey with a working memory quiz incorporating aspects of gamification to engage participants. 5428 participants successfully completed the survey and memory quiz between 8th December 2020 and 5th July 2021 (68.6% non-COVID-19 and 31.4% COVID-19). Most participants (93.3%) completed the survey and memory quiz relatively rapidly (mean time of 8.84 minutes). Categorical regression was used to assess the contribution of COVID status, age, time post-COVID (number of months elapsed since having had COVID), symptoms, ongoing symptoms and gender, followed by non-parametric statistics. A principal component analysis explored the relationship between subjective ratings and objective memory scores. The objective memory scores were significantly correlated with participants’ own assessment of their cognitive function. The factors significantly affecting memory scores were COVID status, age, time post-COVID and ongoing symptoms. Our main finding was a significant reduction in memory scores in all COVID groups (self-reported, positive-tested and hospitalized) compared to the non-COVID group. Memory scores for all COVID groups combined were significantly reduced compared to the non-COVID group in every age category 25 years and over, but not for the youngest age category (18–24 years old). We found that memory scores gradually increased over a period of 17 months post-COVID-19. However, those with ongoing COVID-19 symptoms continued to show a reduction in memory scores. Our findings demonstrate that COVID-19 negatively impacts working memory function, but only in adults aged 25 years and over. Moreover, our results suggest that working memory deficits with COVID-19 can recov
Read more »
CoviRx: A User-Friendly Interface for Systematic Down-Selection of Repurposed Drug Candidates for COVID-19Although various vaccines are now commercially available, they have not been able to stop the spread of COVID-19 infection completely. An excellent strategy to get safe, effective, and affordable COVID-19 treatments quickly is to repurpose drugs that are already approved for other diseases. The process of developing an accurate and standardized drug repurposing dataset requires considerable resources and expertise due to numerous commercially available drugs that could be potentially used to address the SARS-CoV-2 infection. To address this bottleneck, we created the CoviRx.org platform. CoviRx is a user-friendly interface that allows analysis and filtering of large quantities of data, which is onerous to curate manually for COVID-19 drug repurposing. Through CoviRx, the curated data have been made open source to help combat the ongoing pandemic and encourage users to submit their findings on the drugs they have evaluated, in a uniform format that can be validated and checked for integrity by authenticated volunteers. This article discusses the various features of CoviRx, its design principles, and how its functionality is independent of the data it displays. Thus, in the future, this platform can be extended to include any other disease beyond COVID-19.
Read more »
Lockdown frustration grows in China's COVID epicentre despite a surge in casesFood supplies and other deliveries are flung over hastily built barriers, while visitors must call out to friends stuck behind the wall which separates parts of Guangzhou.
Read more »
Additional mRNA COVID vaccine doses could salvage antibody responses in blood cancer patientsAdditional mRNA COVID vaccine doses could salvage antibody responses in blood cancer patients Antibody Blood BloodCancer Cancer Coronavirus Disease COVID Vaccine NatureComms imperialcollege
Read more »
China’s Zero-Covid Tweaks Are A False Flag For Oil Markets | OilPrice.comThe core problem in China’s latest approach to Covid-19 is the same as with most half-measures: that is, they only serve to make the problem worse
Read more »